Nihar info global Limited has submitted its quarterly compliance certificate to the Bombay Stock Exchange, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the quarter ended March 31, 2026, demonstrating the company's commitment to regulatory compliance and investor protection.

Regulatory Compliance Certificate

The company submitted the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 on April 13, 2026. This certificate confirms proper handling of dematerialization procedures during the specified quarter.

Registrar Confirmation

Aarthi Consultants Private Limited, serving as the company's registrar and share transfer agent, issued the compliance certificate on April 3, 2026. The registrar confirmed adherence to required procedures for the period from January 1, 2026 to March 31, 2026.

The registrar certified compliance with the following key requirements:

• Completion of required actions within 15 days of receiving security certificates from depository participants
• Proper listing of dematerialized securities on relevant stock exchanges
• Mutilation and cancellation of physical certificates forwarded by participants
• Substitution of depository name as registered owner in company records

Corporate Communication

The submission was communicated to the Bombay Stock Exchange's Corporate Relations Department by Managing Director Divyesh Nihar Boda. The communication ensures transparency and keeps investors informed about the company's regulatory compliance status.

This quarterly submission represents standard regulatory practice, ensuring proper maintenance of investor records and compliance with securities market regulations. The certificate provides assurance to stakeholders regarding the company's adherence to prescribed dematerialization procedures.

Nihar Info Global Limited's Board of Directors made significant strategic decisions during their meeting on March 18, 2026, approving the divestment of shareholding in subsidiary companies and withdrawing a previously proposed capital increase. The decisions reflect the company's strategic realignment and focus on optimizing its business portfolio.

Subsidiary Divestment Strategy

The Board approved the divestment of the company's shareholding in two subsidiary companies with different valuation approaches based on their respective business activities and financial positions.

Life 108 Healthcare Divestment Details

For Life 108 Healthcare Private Limited, the Board relied on a valuation report dated March 12, 2026, prepared by Ms. Maddula Durga Sushma, a Registered Valuer. The professional assessment determined the fair value at ₹50 per equity share, considering the subsidiary's ongoing business activities and financial performance.

Beastbells Media Strategic Exit

The divestment of Beastbells Media Private Limited follows a different rationale, as the Board noted the company has no significant business operations and negligible financial activity. Consequently, the divestment will proceed at the face value of ₹10 per share, eliminating the need for a formal valuation report.

Regulatory and Timeline Requirements

Both divestments are subject to specific approval processes and timeline constraints:

• Shareholder approval at the ensuing General Meeting
• Other applicable regulatory approvals as required
• Target completion before March 31, 2026

Strategic Policy Reversals

The Board also approved the withdrawal of two previously considered proposals, demonstrating a shift in strategic priorities.

Capital Structure Optimization

The withdrawal of the authorized share capital increase proposal reflects the company's assessment that current capital requirements are adequately met. The Board considered cost optimization and the avoidance of additional compliance requirements as key factors in this decision, indicating no immediate fund-raising or expansion plans.

Investment Strategy Realignment

The decision to drop the investment proposal in Life 108 Healthcare Private Limited aligns with the company's strategic shift toward divestment. The Board determined that further investment in the subsidiary no longer supports the company's business and financial objectives.

Meeting Details

The Board meeting commenced at 4:00 PM IST and concluded at 4:27 PM IST on March 18, 2026. The decisions were communicated to the Bombay Stock Exchange Limited as part of the company's regulatory disclosure obligations under applicable regulations.